Encompass Health Corporation
EHCNYSEHealthcare● Active
$101.92
$-2.09(-2.01%)
Market Cap$10.1B
P/E Ratio—
52W High$127.99
52W Low$92.77
Encompass Health Corporation (EHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
$1.60
Est. $1.51 · +6.0%
Revenue
$1.59B
Est. $1.57B · +1.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 11-Quarter EPS Beat Streak
EHC reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.07
Rev. $15.39B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.07
Rev. Est.$15.39B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $1.48 | — | — | — | $1.57B | — |
| ▲ Q2 FY2026 | Apr 30, 2026 | $1.51 | $1.60 | +6.0% | $1.59B | $1.57B | +1.2% |
| ▲ Q1 FY2026 | Feb 5, 2026 | $1.29 | $1.46 | +13.2% | $1.54B | $1.54B | +0.3% |
| ▲ Q4 FY2025 | Oct 29, 2025 | $1.19 | $1.23 | +3.4% | $1.48B | $1.54B | -4.1% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $1.23 | $1.40 | +13.8% | $1.46B | $1.43B | +2.1% |
| ▲ Q2 FY2025 | Apr 24, 2025 | $1.19 | $1.37 | +15.1% | $1.46B | $1.43B | +2.1% |
| ▲ Q1 FY2025 | Feb 6, 2025 | $1.05 | $1.17 | +11.4% | $1.41B | $1.38B | +1.7% |
| ▲ Q4 FY2024 | Oct 28, 2024 | $0.94 | $1.03 | +9.6% | $1.35B | $1.38B | -2.0% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$1.48
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Beat
EPS Actual
$1.60
EPS Est.
$1.51
EPS Surpr.
+6.0%
Revenue
$1.59B
Q1 FY2026
Feb 5, 2026Beat
EPS Actual
$1.46
EPS Est.
$1.29
EPS Surpr.
+13.2%
Revenue
$1.54B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
$1.23
EPS Est.
$1.19
EPS Surpr.
+3.4%
Revenue
$1.48B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$1.40
EPS Est.
$1.23
EPS Surpr.
+13.8%
Revenue
$1.46B
Q2 FY2025
Apr 24, 2025Beat
EPS Actual
$1.37
EPS Est.
$1.19
EPS Surpr.
+15.1%
Revenue
$1.46B
Q1 FY2025
Feb 6, 2025Beat
EPS Actual
$1.17
EPS Est.
$1.05
EPS Surpr.
+11.4%
Revenue
$1.41B
Q4 FY2024
Oct 28, 2024Beat
EPS Actual
$1.03
EPS Est.
$0.94
EPS Surpr.
+9.6%
Revenue
$1.35B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.79 | $1.80 | $1.81 | 4 |
| Q3 FY2028 | $1.58 | $1.59 | $1.61 | 6 |
| Q2 FY2028 | $1.76 | $1.77 | $1.78 | 4 |
| Q1 FY2028 | $1.81 | $1.82 | $1.83 | 4 |
| Q4 FY2027 | $1.69 | $1.70 | $1.72 | 3 |
| Q3 FY2027 | $1.49 | $1.50 | $1.51 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.9B | $1.9B | $2.0B | 6 |
| Q3 FY2028 | $1.8B | $1.9B | $1.9B | 3 |
| Q2 FY2028 | $1.8B | $1.8B | $1.8B | 5 |
| Q1 FY2028 | $1.8B | $1.8B | $1.9B | 3 |
| Q4 FY2027 | $1.8B | $1.8B | $1.8B | 7 |
| Q3 FY2027 | $1.7B | $1.7B | $1.7B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 30, 2026 | +6.0% | $102.61 | $100.00 | -2.54% |
| ▲ Q1 FY2026 | Feb 5, 2026 | +13.2% | $95.66 | $99.56 | +4.08% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +3.4% | $126.28 | $125.63 | -0.51% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +13.8% | $108.53 | $109.50 | +0.89% |
| ▲ Q2 FY2025 | Apr 24, 2025 | +15.1% | $100.72 | $101.41 | +0.69% |
| ▲ Q1 FY2025 | Feb 6, 2025 | +11.4% | $102.20 | $98.60 | -3.52% |
| ▲ Q4 FY2024 | Oct 28, 2024 | +9.6% | $93.46 | $93.09 | -0.40% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +9.9% | $92.71 | $89.67 | -3.28% |
Q2 FY2026-2.54%
Report Date
Apr 30, 2026
EPS Beat/Miss
+6.0%
Price Before
$102.61
Price After
$100.00
Q1 FY2026+4.08%
Report Date
Feb 5, 2026
EPS Beat/Miss
+13.2%
Price Before
$95.66
Price After
$99.56
Q4 FY2025-0.51%
Report Date
Oct 29, 2025
EPS Beat/Miss
+3.4%
Price Before
$126.28
Price After
$125.63
Q3 FY2025+0.89%
Report Date
Aug 4, 2025
EPS Beat/Miss
+13.8%
Price Before
$108.53
Price After
$109.50
Q2 FY2025+0.69%
Report Date
Apr 24, 2025
EPS Beat/Miss
+15.1%
Price Before
$100.72
Price After
$101.41
Q1 FY2025-3.52%
Report Date
Feb 6, 2025
EPS Beat/Miss
+11.4%
Price Before
$102.20
Price After
$98.60
Q4 FY2024-0.40%
Report Date
Oct 28, 2024
EPS Beat/Miss
+9.6%
Price Before
$93.46
Price After
$93.09
Q3 FY2024-3.28%
Report Date
Aug 5, 2024
EPS Beat/Miss
+9.9%
Price Before
$92.71
Price After
$89.67
Avg Beat Reaction-0.57%
Beat Rate8 / 8 quarters
Largest Move+4.08% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EHC ends December
Encompass Health Corporation (EHC) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $1.60 — beating the analyst consensus of $1.51 by +6.0%. EHC has beaten EPS estimates for 11 consecutive quarters. The next EHC earnings date is expected around September 1, 2026.
Each quarter, investors track EHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EHC earnings · 5 questionsEncompass Health Corporation's next earnings report is expected around September 1, 2026. EHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EHC historically reports after market close (AMC).
EHC earnings datewhen is EHC earningsEHC next earnings datewhen does EHC report earningsEHC earnings calendar
▸ Source: FMP · Encompass Health Corporation SEC filings · US GAAP · Encompass Health Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026